Non-CDK-bound p27 (p27^NCDK) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways

p27Kip1 (p27) tumour suppressor protein is regulated by multiple mechanisms including its turnover, localization and complex formation with its key targets, cyclin-dependent kinases (CDK) and cyclins. We have earlier shown that p27 exists in cells in a form that lacks cyclin/CDK interactions (hence non-CDK, p27^NCDK) but the nature of p27^NCDK has remained unresolved. Here we demonstrate that the epitope recognized by the p27^NCDK-specific antibody resides in the p27 CDK-interaction domain and that p27^NCDK is regulated by the balance of CDK inhibitors and cyclin-CDK complexes. We find that signalling by cellular growth promoting pathways, like phosphoinositol 3-kinase (PI3K) and specifically Akt/PKB kinase, inversely correlates with p27^NCDK levels whereas total p27 levels are unaffected. p27^NCDK, but not total p27, is increased by cellular perturbations such as hyperosmotic and metabolic stress and activation of AMP-activated protein kinase (AMPK). By using AMPK catalytic subunit proficient and deficient cells we further demonstrate that the AMPK pathway governs p27^NCDK responses to metabolic stress and PI3K inhibition. These results indicate that p27^NCDK is a sensitive marker for both cell stress and proliferation over and above p27 and is regulated by Akt/PKB and AMPK pathways.